Consilium MedicumConsilium MedicumConsilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum92785ArticlesСтатьиResearch ArticleOzhirenie u molodykh zhenshchin kak pervoe proyavlenie metabolicheskogo sindroma: poisk effektivnykh metodov korrektsiiОжирение у молодых женщин как первое проявление метаболического синдрома: поиск эффективных методов коррекцииTkachevaO. NТкачеваО. Н

Кафедра клинической фармакологии и фармакотерапии

GalyautdinovaA. YuГаляутдиноваА. Ю

Кафедра клинической фармакологии и фармакотерапии

RunikhinaN. KРунихинаН. К

Кафедра клинической фармакологии и фармакотерапии

Московский государственный медико-стоматологический университет15092008109VOL 10, NO9 (2008)ТОМ 10, №9 (2008)757728122021Copyright ©; 2008, Consilium MedicumCopyright ©; 2008, ООО "Консилиум Медикум"2008Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://consilium.orscience.ru/2075-1753/article/view/92785

Проблема ожирения привлекает внимание исследователей в том числе и потому, что данное заболевание является основным компонентом метаболического синдрома (МС) – состояния, при котором сочетается ряд факторов и многократно увеличивается риск развития ССЗ. Проблема МС является чрезвычайно актуальной во всем мире. Несмотря на большое количество научных изысканий, МС нуждается в дальнейших исследованиях, необходимых для понимания того, когда и как нужно лечить.

Barret-Connor E.L. Obesity, atherosclerosis, and coronary artery disease. Annal Intern Med 1985; 103: 1010–19.Borsika A Rabin, Tegan K. Boehmer, Ross C. Brownson Cross - national comparison of environmental and policy correlates of obesity in Europe. Eur J Public Health 2007; 17 (1): 53–61.Campbell I.W, Howlett C.S. Worldwide experience of metformin asa glucose - lowering agent:a meta - analysis. Diabetes Metab Rev 1995; 11 (Suppl. 1): S57–S62.Caruso A, Paradisi G, Ferrazzani S et al. Effect of maternal carbohydrate metabolism in fetal growth. Obstet Gynecol 1998; 92: 8–12.Fleming R et al. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin ina randomized double blind placebo - controlled trial. J Clin Endocrinol Metab 2002; 87: 569–74.Gokcel A, Gumurdulu Y, Karakose H et al. Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity. Diabetes Obesity and Metabolism 2002; 4: Issue 1.Hubert H.B, Fienleib M et al. Obesity as an independent risk factor for cardiovascular disease:a 26-year follow - up of participants in the Framingham Heart Study. Circulation 1983; 67: 986–77.Kissebah A.H, Krakower G.R. Regional adiposity and morbidity. Physiol Rev 1994; 74: 761–811.Kliegman R, Gross T, Morton S, Dunnington R. Intrauterine growth and postnatal fasting metabolism in infants of obese mothers. J Pediatr 1984; 104: 601–7.Kocak M et al. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate - resistant women with polycystic ovary syndrome. Fertil Steril 2002; 77: 101–6.Lee A, Morley J. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non - insulin - dependent diabetes. Obes Res 1998; 6: 47–53.Mannucci E, Ognibene A, Cremasco F. Effect of metformin on glucagon - like peptide 1 (glp-1) and leptin levels in obese nondiabetic subjects. Diabetes Care 2001; 24 (3): 489–94.Moghetti P et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome:a randomized, double - blind, placebo - controlled 6-month trial, followed by open, long - term clinical evaluation. J Clin Endocrinol Metab 2000; 85: 139–46.Morin-Papunen L.C et al. Endocrine and metabolic effects of metformin versus ethinyl estradiol - cyproterone acetate in obese women with polycystic ovary syndrome:a randomized study. J Clin Endocrinol Metab 2000; 85: 3161–8.Nestler J.E et al. Effects of metformin on spontaneous and clomiphene - induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998; 338: 1876–80.Nestler J.E, Jakubowicz D.J. Decreases in ovarian cytochrome P450c17a activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996; 335: 617–23.Norman R.J et al. Metformin and intervention in polycystic ovary syndrome. Med J Aust 2001; 174: 580–3.Obesity and overweight What are overweight and obesity? WHO Fact sheet N311 September 2006 http://www.who.int/mediacentre/factsheets/fs311/en/Obesity: preventing and managing the global epidemic Report ofa WHO Consultation Geneva, World Health Organization, 2004.Ogburn P.L, Goldstein M, Walker J, Stonestreet B.S. Prolonged hyperinsulinemia reduces plasma fatty acid levels in the major lipid groups in fetal sheep. Am J Obstet Gynecol 1989; 161: 728–32.Paolisso G, Amato L, Eccellente R et al. Effect of metformin on food intake in obese subjects. Eur J Clin Invest 1998; 28: 441–6.Pasquali R et al. Effect of long - term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000; 85: 2767–74.Pettitt D.J, Nelson R.G, Saad M.F et al. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care 1993; 16: 310–4.Ravelli A.C.J, van der Meulen J.H.P, Bleker O.P et al. Body size of newborn babies after prenatal exposure to the Dutch famine of 1944–45. In: Prenatal exposure to the Dutch famine and glucose tolerance and obesity at age 50. University of Amsterdam. 1999; 5: 51–62.Ravelli A.C.J, van der Meulen J.H.P, Osmond C et al. Obesity after prenatal exposure to famine in men and women at the age of 50. In: Prenatal exposure to the Dutch Famine and glucose tolerance and obesity at age 50. University of Amsterdam. 1999; 5: 75–87.Reaven G.M, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities – the role of insulin resistance and sympathoadrenal system. New Engl J Med 1996; 334: 374–81.Reilly J.J, Jackson D.M et al. Total energy expenditure and physical activity in young Scottish children: mixed longitudinal study. Lancet 2004; 363: 211–2.Rouru J, Hupponen R, Pesonen U, Koulu M. Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese Zucker rats. Life Sci 1992; 50: 1813–20.Sattar N, Greer I.A. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? Br Med J 2002; 325: 157–60.Sebire N.J, Jolly M et al. Maternal obesity and pregnancy outcome:a study of 287 213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25: 1175–82.Sermer M, Naylor C.D et al. The Toronto Tri - Hospital Gestational Diabetes Project. A preliminary review. Diabetes Care 1998; 21: B33–B42.Stadtmauer L.A et al. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin - like growth factors. Fertil Steril 2001; 75: 505–9.Stampfer M.J, Hu F.B et al. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000; 343: 16–22.Stein Z, Susser M. The Dutch famine, 1944–45, and the reproductive process. I. Effects on six indices at birth. Pediatr Res 1975; 9: 70–6.Williams D. Pregnancy:a stress test for life. Curr Opin Obstet Gynecol 2003; 5 (6): 465–71.Лекарственные средства. Справочник лекарственных средств, отпускаемых по рецепту врача (фельдшера) при оказании дополнительной бесплатной медицинской помощи отдельным категориям граждан, имеющим право на получение государственной социальной помощи. Под ред. Р.У.Хабриева, А.Г.Чучалина. 2005; 2.Чернуха Г.Е. Ожирение как фактор риска нарушений репродуктивной системыу женщин. Consilium Medicum 2007; 9 (6): 84–6.Cleophas Ton J. Experimental evidence of selective antagonistic action of Nebivolol onfit - adrenergic receptors. J Clin Med 1998; II: 1–8.Gao Y et al. Nebivolol induces endotelium - dependent relaxations of canine coronary arteries. J Cardiovasc Pharmacol 1991; 17: 964–9.Cockcroft J.R, Chowenczyk P.H, Brett S.E et al. Nebivolol vasodilates human forearm vasculate: evidence for L - arginine/NO - dependent mechanism. J Parmacol Exp Therapeutics 1995; 274 (3): 1067–71.